Cytolytic CD4+ and CD8+ Regulatory T-Cells and Implications for Developing Immunotherapies to Combat Graft-Versus-Host Disease is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 50 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: F30 HL156312
NHLBI NIH HHS
Grant: R01 HL155114
NHLBI NIH HHS
Grant: R01 HL147324
NIAID NIH HHS
Grant: P01 AI056299
NIAID NIH HHS
Grant: R37 AI034495
NHLBI NIH HHS
Grant: R01 HL118979
NCI NIH HHS
Grant: P01 CA065493
NHLBI NIH HHS
Grant: R01 HL056067
NIAID NIH HHS
Grant: T32 AI007313
National Institutes of Health
Grant: 5R37HL056067-08
T CELL TARGETING FOR GVHD
National Institutes of Health
Grant: 5F30HL156312-02
Enhancing Treg Therapeutic Efficacy in GVHD with CARs
National Institutes of Health
Grant: 5T32AI007313-20
Immunology Training Program
National Institutes of Health
Grant: 1R01HL155114-01
Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease
National Institutes of Health
Grant: 5R01EB011879-02
Foreign Body Response as a Performance Metric for Implanted Scaffolds
National Institute of Allergy and Infectious Diseases
National Heart, Lung, and Blood Institute
FWCI
2.95
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals